Debt-to-equity of Alaunos Therapeutics, Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Alaunos Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • Alaunos Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 39%, a 40% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Alaunos Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 39% +11% +40% 30 Sep 2025
Q2 2025 38% +4.9% +15% 30 Jun 2025
Q1 2025 36% +4.1% +13% 31 Mar 2025
Q4 2024 27% -19% -40% 31 Dec 2024
Q3 2024 28% -27% -49% 30 Sep 2024
Q2 2024 34% -38% -53% 30 Jun 2024
Q1 2024 32% -49% -61% 31 Mar 2024
Q4 2023 46% -36% -44% 31 Dec 2023
Q3 2023 55% -24% -30% 30 Sep 2023
Q2 2023 71% +1.3% +1.9% 30 Jun 2023
Q1 2023 82% +30% +58% 31 Mar 2023
Q4 2022 82% +44% +114% 31 Dec 2022
Q3 2022 79% +51% +181% 30 Sep 2022
Q2 2022 70% +52% +283% 30 Jun 2022
Q1 2022 52% +36% +229% 31 Mar 2022
Q4 2021 38% +25% +196% 31 Dec 2021
Q3 2021 28% +16% +130% 30 Sep 2021
Q2 2021 18% +6.9% +60% 30 Jun 2021
Q1 2021 16% +3.3% +26% 31 Mar 2021
Q4 2020 13% -0.77% -5.6% 31 Dec 2020
Q3 2020 12% -0.53% -4.2% 30 Sep 2020
Q2 2020 11% -130% -92% 30 Jun 2020
Q1 2020 12% +117% 31 Mar 2020
Q4 2019 14% +72% 31 Dec 2019
Q3 2019 13% +60% 30 Sep 2019
Q2 2019 142% +196% 30 Jun 2019
Q1 2019 -105% -41% -63% 31 Mar 2019
Q4 2018 -59% +11% +15% 31 Dec 2018
Q3 2018 -47% +26% +36% 30 Sep 2018
Q2 2018 -54% +24% +30% 30 Jun 2018
Q1 2018 -64% +60% +48% 31 Mar 2018
Q4 2017 -69% +243% +78% 31 Dec 2017
Q3 2017 -73% -832% -110% 30 Sep 2017
Q2 2017 -78% -266% -141% 30 Jun 2017
Q1 2017 -124% -184% -305% 31 Mar 2017
Q4 2016 -312% -354% -855% 31 Dec 2016
Q3 2016 758% +726% +2254% 30 Sep 2016
Q2 2016 188% +172% +1066% 30 Jun 2016
Q1 2016 60% +37% +162% 31 Mar 2016
Q4 2015 41% -0.87% -2.1% 31 Dec 2015
Q3 2015 32% -13% -28% 30 Sep 2015
Q2 2015 16% -50% -76% 30 Jun 2015
Q1 2015 23% -61% -73% 31 Mar 2015
Q4 2014 42% -48% -53% 31 Dec 2014
Q3 2014 45% -58% -56% 30 Sep 2014
Q2 2014 66% -15% -18% 30 Jun 2014
Q1 2014 84% +15% +21% 31 Mar 2014
Q4 2013 91% +30% +48% 31 Dec 2013
Q3 2013 103% +46% +81% 30 Sep 2013
Q2 2013 81% +31% +62% 30 Jun 2013
Q1 2013 70% +20% +41% 31 Mar 2013
Q4 2012 61% 31 Dec 2012
Q3 2012 57% 30 Sep 2012
Q2 2012 50% 30 Jun 2012
Q1 2012 49% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.